A bibliometric analysis of the 100 most-influential papers in the field of anti-diabetic drugs

References

• Sampson M, Davies I, Gavrilovic J et al. Plasma matrix metalloproteinases, low density lipoprotein oxidisability and soluble adhesion molecules after a glucose load in Type II diabetes. Cardiovasc. Diabetol. 3, 7 (2004).
   PubMed Web of Science ®Google Scholar
• Zheng Y, Ley SH, Hu FB. Global aetiology and epidemiology of Type II diabetes mellitus and its complications. Nat. Rev. Endocrinol. 14(2), 88–98 (2018).
   PubMed Web of Science ®Google Scholar
• Schmidt AM. Highlighting diabetes mellitus: the epidemic continues. Arterioscler. Thromb. Vasc. Biol. 38(1), e1–e8 (2018).
   PubMed Web of Science ®Google Scholar
• Huang K, Zhu J, Xu S, Zhu R, Chen X. Bibliometric and visualized analysis of 2011–2020 publications on physical activity therapy for diabetes. Front. Med. 9, 807411 (2022).
   Web of Science ®Google Scholar
• Song Y, Ma P, Gao Y, Xiao P, Xu L, Liu H. A bibliometrics analysis of metformin development from 1980 to 2019. Front. Pharmacol. 12, 645810 (2021).
   PubMed Web of Science ®Google Scholar
• Zhang W, Zhang S, Dong C et al. A bibliometric analysis of RNA methylation in diabetes mellitus and its complications from 2002 to 2022. Front. Endocrinol. 13, 997034 (2022).
   PubMed Web of Science ®Google Scholar
• Gupta BM, Pal R, Rohilla L, Dayal D. Bibliometric analysis of diabetes research in relation to the COVID-19 pandemic. J. Diabetol. 12, 350 (2021).
   Google Scholar
• Hirsch JE. An index to quantify an individual's scientific research output. Proc. Natl Acad. Sci. USA 102, 16569–16572 (2005).
   PubMed Web of Science ®Google Scholar
• Ellegaard O, Wallin JA. The bibliometric analysis of scholarly production: how great is the impact? Scientometrics 105, 1809–1831 (2015).
   PubMed Web of Science ®Google Scholar
• Belter CW. Bibliometric indicators: opportunities and limits. J. Med. Libr. Assoc. 103, 219–221 (2015).
   PubMed Web of Science ®Google Scholar
• Yang R, Li J, Qin Y et al. A bibliometric analysis of cerebral microbleeds and cognitive impairment. Brain Cogn. 169, 105999 (2023 Jul).
   PubMed Web of Science ®Google Scholar
• Sun HL, Bai W, Li XH et al. Schizophrenia and inflammation research: a bibliometric analysis. Front. Immunol. 13, 907851 (2022 Jun 9).
   PubMed Web of Science ®Google Scholar
• Wang Y, Zhai X, Liu C, Wang N, Wang Y. Trends of triple negative breast cancer research (2007–2015): a bibliometric study. Medicine 95(46), e5427 (2016).
   PubMed Web of Science ®Google Scholar
• Conte ML, Liu J, Schnell S, Omary MB. Globalization and changing trends of biomedical research output. JCI Insight 2(12), e95206 (2017).
   PubMed Web of Science ®Google Scholar
• Evangeline C. Current trends in biomedical research. J. Biol. Today's World 10(2), 001 (2021).
   Google Scholar
• Hung BT, Long NP, Hung le P et al. Research trends in evidence-based medicine: a joinpoint regression analysis of more than 50years of publication data. PLOS ONE 10(4), e0121054 (2015).
   PubMed Web of Science ®Google Scholar
• Ganesan K, Rana MBM, Sultan S.Oral hypoglycemic medications. In: StatPearls [Internet]. StatPearls Publishing, FL, USA (2022). https://www.ncbi.nlm.nih.gov/books/NBK482386/
   Google Scholar
• Usman MS, Siddiqi TJ, Memon MM et al. Sodium-glucose co-transporter 2 inhibitors and cardiovascular outcomes: a systematic review and meta-analysis. Eur. J. Prev. Cardiol. 25, 495–502 (2018).
   PubMed Web of Science ®Google Scholar
• Roldan-Valadez E, Salazar-Ruiz SY, Ibarra-Contreras R, Rios C. Current concepts on bibliometrics: a brief review about impact factor, Eigenfactor score, CiteScore, SCImago Journal Rank, Source-Normalised Impact per Paper, H-index, and alternative metrics. Ir. J. Med. Sci. 188, 939–951 (2019).
   PubMed Web of Science ®Google Scholar
• Balakumar P, Maung-U K, Jagadeesh G. Prevalence and prevention of cardiovascular disease and diabetes mellitus. Pharmacol. Res. 113, 600–609 (2016).
   PubMed Web of Science ®Google Scholar
• Koye DN, Magliano DJ, Nelson RG, Pavkov ME. The global epidemiology of diabetes and kidney disease. Adv Chronic Kidney Dis. 25, 121–132 (2018).
   PubMed Web of Science ®Google Scholar
• Thibault V, Bélanger M, LeBlanc E et al. Factors that could explain the increasing prevalence of Type II diabetes among adults in a Canadian province: a critical review and analysis. Diabetol. Metab. Syndr. 8, 71 (2016).
   PubMed Web of Science ®Google Scholar
• Satman I, Omer B, Tutuncu Y et al. TURDEP-II Study Group. Twelve-year trends in the prevalence and risk factors of diabetes and prediabetes in Turkish adults. Eur. J. Epidemiol. 28, 169–180 (2013).
   PubMed Web of Science ®Google Scholar
• Ahmadieh H, Azar ST. The role of incretin-based therapies in prediabetes: a review. Prim. Care Diabetes 8, 286–294 (2014).
   PubMed Web of Science ®Google Scholar
• Dardano A, Miccoli R, Bianchi C, Daniele G, Del Prato S. Invited review. Series: implications of the recent CVOTs in Type II diabetes: which patients for GLP-1RA or SGLT-2 inhibitor? Diabetes Res. Clin. Pract. 162, 108112 (2020).
   PubMed Web of Science ®Google Scholar
• Grant RW, Donner TW, Fradkin JE et al. Standards of medical care in diabetes – 2015. Diabetes Care 38, S1–S2 (2015).
   Web of Science ®Google Scholar
• Rosak C, Mertes G. Critical evaluation of the role of acarbose in the treatment of diabetes: patient considerations. Diabetes Metab. Syndr. Obes. 5, 357–367 (2012).
   PubMedGoogle Scholar
• Sola D, Rossi L, Schianca GP et al. Sulfonylureas and their use in clinical practice. Arch. Med. Sci. 11(4), 840–848 (2015).
   PubMed Web of Science ®Google Scholar
• Waseem Y, Mahmood S, Siddiqi R et al. Gender differences amongst board members of endocrinology and diabetes societies. Endocrine. 64, 496–499 (2019).
   PubMed Web of Science ®Google Scholar
• Dunne JL, Maizel JL, Posgai AL, Atkinson MA, DiMeglio LA. The women's leadership gap in diabetes: a call for equity and excellence. Diabetes 70, 1623–1633 (2021).
   PubMed Web of Science ®Google Scholar
• Pololi LH, Civian JT, Brennan RT, Dottolo AL, Krupat E. Experiencing the culture of academic medicine: gender matters, a national study. J. Gen. Intern. Med. 28(2), 201–207 (2013).
   PubMed Web of Science ®Google Scholar
• Smith KA, Arlotta P, Watt FM, Solomon SL. Initiative on Women in Science and Engineering Working Group. Seven actionable strategies for advancing women in science, engineering, and medicine. Cell Stem Cell. 16(3), 221–224 (2015).
   PubMed Web of Science ®Google Scholar
• Masur SK. Invisible woman? Trends Cell Biol. 25(8), 437–439 (2015).
   PubMed Web of Science ®Google Scholar
• Type II diabetes market (by drug class: Dipeptidyl peptidase-4, inhibitors, glucagon-like peptide, receptor agonists, thiazolidinediones, alpha-glucosidase inhibitors, sulfonylureas, secretagogues, biguanides, sodium glucose cotransport 2 inhibitors; by Application: Hospital Pharmacies, retail pharmacies, online pharmacies, others) - global industry analysis, size, share, growth, trends, Regional Outlook, and forecast 2022–2030. Precedence Research (2023) ( Internet). https://www.precedenceresearch.com/type-2-diabetes-market
   Google Scholar
• Khalidi N, Atallah B, Alkatheri AM, Albekairy A, Qandil AM. Post market research of oral anti-diabetic drugs: metformin, glipizide and pioglitazone. J. Appl. Pharmaceut. Sci. 4, 061–067 (2014).
   Google Scholar
• Knowler WC, Barrett-Connor E, Fowler SE et al. Reduction in the incidence of Type II diabetes with lifestyle intervention or metformin. N. Engl. J. Med. 346(6), 393–403 (2002).
   PubMed Web of Science ®Google Scholar
• van den Berghe G, Wouters P, Weekers F et al. Intensive insulin therapy in critically ill patients. N. Engl. J. Med. 345(19), 1359–1367 (2001).
   PubMed Web of Science ®Google Scholar
• Khan M, Rahman-Shepherd A, Bory S et al. How conflicts of interest hinder effective regulation of healthcare: an analysis of antimicrobial use regulation in Cambodia, Indonesia and Pakistan. BMJ Glob. Health 7(5), e008596 (2022).
   PubMed Web of Science ®Google Scholar
• Bekelman JE, Li Y, Gross CP. Scope and impact of financial conflicts of interest in biomedical research: a systematic review. JAMA 289(4), 454–465 (2003).
   PubMed Web of Science ®Google Scholar
• Romain PL. Conflicts of interest in research: looking out for number one means keeping the primary interest front and center. Curr. Rev. Musculoskelet. Med. 8(2), 122–127 (2015).
   PubMedGoogle Scholar
• Loewenstein G, Sah S, Cain DM. The unintended consequences of conflict of interest disclosure. JAMA 307(7), 669–670 (2012).
   PubMed Web of Science ®Google Scholar
• Cernea S, Raz I. Insulin Therapy: Future Perspectives. Am. J. Ther. 27(1), e121–e132 (2020).
   PubMed Web of Science ®Google Scholar
• Falagas ME, Pitsouni EI, Malietzis GA, Pappas G. Comparison of PubMed, Scopus, Web of Science, and Google Scholar: strengths and weaknesses. FASEB J. 22, 338–342 (2008).
   PubMed Web of Science ®Google Scholar
• Kulkarni AV, Aziz B, Shams I, Busse JW. Author self-citation in the general medicine literature. PLOS ONE 6(6), e20885 (2011).
   PubMed Web of Science ®Google Scholar